Physicians Decry Pseudo-Science of
Physicians Decry Pseudo-Science of Transgenderism,
‘Absurd’ to Say Anyone is Born Into ‘Wrong Body’
Normalizing Gender Dysphoria is Dangerous and Unethical
August 3, 2016
Gender Dysphoria in Children :
In its updated statementthe American College of Pediatricians (College) calls for an end to the normalization of gender dysphoria (GD) in children because it has led to the ongoing experimentation upon, and sterilization of, confused children. Children with GD believe that they are something other than their biological sex. For children experiencing GD before the age of puberty, the confusion resolves over 80 percent of the time by late adolescence. There is a suppressed debate among professionals regarding the new treatment “standard” for childhood GD. This media-popularized standard involves the use of medicines that block puberty followed by life-long use of toxic cross-sex hormones—a combination that results in the sterilization of minors and other significant health risks. A review of current medical literature finds this approach to be rooted in an unscientific gender ideology that violates the long-standing medical ethics principle of “First do no harm.”
Mandates by public institutions to force the acceptance of GD as a normal variant of child development and require social accommodation, toxic hormone therapy and surgical removal of healthy body parts, are misguided and dangerous. The Association of American Physicians and Surgeons, the Christian Medical Association, and the Catholic Medical Association share the College’s concern over this approach. Together our groups represent over 20,000 physicians and health professionals. Opposition also exists among liberal-leaning healthcare professionals who have created an online community known as Youth Trans Critical Professionals. However, those who dare to speak out in support of “First do no harm” often encounter significant public and private harassment, and many have lost or will lose their jobs.
Dr. Michelle Cretella, President of the College states, “We live at a time in which social agendas often bias the results of research and lead to the development of false medical standards. Those who honorably speak out against this are chastised. Young children are being permanently sterilized and surgically maimed under the guise of treating a condition that would otherwise resolve in over 80% of them. This is criminal.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Fresh Breeze in the Boardroom Bank of America isn't sitting still. They're shaking things up by bringing in Jim Fitterling and Bill Thomas. Now, why’s that a big deal for those watching NYSE:BAC? Well, these guys pack heavy resumes, and their experience could steer the ship with precision across turbulent financial waters. The Minds Behind the Names Let's chew the fat...
Continue Reading
Peering into the Heart of Microtubules Ever squint at a tapestry, only to find a rogue thread ruining the pattern? Well, that’s somewhat what scientists at Kanazawa University have found with microtubules, those tiny rods in our cells that usually keep it all together. Using some pretty fancy tech called high-speed atomic force microscopy, these folks peered into the...
Continue Reading
AI Meets Human Expertise in Clinical Decision-Making Look, in the labyrinth of healthcare, we’re seeing a revolution with AI stepping in—not to replace the doctor, but to stand alongside them like a trusty assistant. Tairex, from the halls of Tsinghua University's Institute for AI Industry Research (AIR), has thrown its hat into this ring by unveiling their...
Continue Reading
Sometimes, the world flips its script. In 2026, five fearless innovators grabbed the spotlight at the Broad Institute. If you're not familiar with Graeme Clark, Erwin and Ingeborg Hochmair, Michael Merzenich, or Blake Wilson, well then, you've been snoozing under a rock. These folks were decorated with the prestigious Merkin Prize for crafting the modern cochlear...
Continue Reading
When Deals Leave Shareholders in the Lurch Here's the deal, folks—three companies are under scrutiny for transactions that might leave their shareholders dry while insiders make a pretty penny. Priority Technology Holdings, Inc. (NASDAQ:PRTH), Baldwin Group, Inc. (NASDAQ:BWIN), and CCC Intelligent Solutions Holdings Inc. (NASDAQ:CCC) are being probed by Halper Sadeh LLC...
Continue Reading
Strong Magnets and Smarter Tracking: A Golfer's Companion Forget about the agony of misplacing that pricey bit of tech you thought was secure on your golf cart. ROKFORM's new Rangefinder 18X promises to stick around with its bold tech debut. We're talking a magnet on steroids here—up to three times stronger than the competition. If your last purchase slipped on a bumpy...
Continue Reading
Everyone’s eyeballs are glued to the burning issue of lithium-ion battery fires, and for good reason. They’re ticking time bombs, especially in those fancy new electric vehicles and gadgets. But stepping into the ring with solutions like they’re fighting windmills, Packaging and Crating Technologies (PACT®) took the spotlight at the recent Battery Show in Detroit,...
Continue Reading
A Seasoned Leader Bolsters RID's Ambitions Mario Savarese has joined Rapid Infection Diagnostics Inc.'s Strategic Advisory Board, and let me tell ya, this move's got potential. Appointing a heavyweight like Savarese as an advisor isn’t just a nod to his hefty resume. It’s about vaulting a burgeoning company into the big leagues. He's got over 20 years steering a ship...
Continue Reading
A New Pioneer in AI Business Transformation Who would’ve thought two companies merging into one could shake things up this much? Introducing MOOV—a fresh sprout in the Canadian AI scene that's setting out to redefine how businesses across North America get stuff done. By blending the robust AI chops of Moov AI with the strategic design finesse of Nurun, this firm’s...
Continue Reading
Axis Fab Unveils a Cutting-edge Hub No shortcuts here, folks. Axis Fabrication & Machine is rolling out the red carpet on November 4, 2026, to flaunt their brand-new 78,000-square-foot manufacturing beast in Rockford, Tennessee. We're talking about a $24 million bet on the future—a clear signal Axis is doubling down on the surge of industrial dynamism sweeping East...
Continue Reading
Top 5 Most Recently Viewed Articles
Walt Disney's Market Insights and Investor Sentiment Investors are increasingly focusing on Walt Disney (NYSE: DIS), reflecting a positive sentiment that market analysts should take note of. Scrutinizing options activity can reveal crucial hints about future stock movements. Our latest research suggests that major players in the options market are taking significant...
Continue Reading
Perdue AgriBusiness Takes Action on PFAS Contamination Issues Recent testing at the Perdue AgriBusiness facility has brought to light concerning levels of Per- and Polyfluoroalkyl Substances (PFAS). These chemicals, often referred to as 'forever chemicals' due to their persistence in the environment, have raised alarms among local communities and officials. Perdue...
Continue Reading
Old Republic International Earnings Call Announcement Old Republic International Corporation (NYSE: ORI) has announced important details regarding its upcoming earnings call for the third quarter of 2024. This call will provide investors and stakeholders with insights into the company's financial performance and future outlook. Earnings Report Date The company is set to...
Continue Reading
WisdomTree Fund Prices Overview In today’s ever-evolving financial landscape, understanding fund prices is crucial for investors. WisdomTree Issuer plc offers a range of funds that are pivotal to the investment strategy of many. With the latest updates from the fund market, let's delve into the details of some notable WisdomTree funds available for investment. Key...
Continue Reading
Anticipating Enbridge's Quarterly Earnings Results Soon Enbridge (NYSE: ENB) is set to announce its quarterly earnings soon. Investors are excited and have high expectations for the outcome. Analysts predict an earnings per share (EPS) of $0.44, which indicates a careful optimism surrounding the announcement. As the date approaches, many investors are looking for insights...
Continue Reading